Added to YB: 2026-01-22
Pitch date: 2026-01-21
LLY [bullish]
Eli Lilly and Company
-4.97%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
Market Cap
$911.7B
Pitch Price
$1.1K
Price Target
N/A
Dividend
0.68%
EV/EBITDA
29.72
P/E
44.47
EV/Sales
14.55
Sector
Pharmaceuticals
Category
growth
Show full summary:
Eli Lilly - Selling Puts
LLY: Selling $870 puts expiring Feb 27 for $6.60 premium, banking on 16.5% downside protection with stock at $1,042. Feb 5 earnings expecting 40% EPS growth to $7.50 driven by Mounjaro/Zepbound dominance. Orforglipron obesity pill FDA decision due Q2 2026. IV crush post-earnings key catalyst.
Read full article (2 min)